Industry News

Innovent Presents Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...

2022-06-06 08:08 3904

Innovent Presents Clinical Data of Phase I Study for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Solid Tumors at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...

2022-06-06 08:00 3995

Innovent and IASO Bio Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma

SAN FRANCISCO and SUZHOU, China, June 6, 2022  /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2022-06-06 08:00 3725

OnRobot Palletizer Takes on Market with Unrivalled Ease-of-Use and Speed of Deployment in Complete, Affordable, Package

OnRobot Palletizer is a powerful, automated palletizing hardware and software solution that combines unprecedented affordability, performance and fast integration with a small footprint to deliver flexible palletizing automation to companies of all sizes. SINGAPORE, June 6, 2022 /PRNewswire/ -- ...

2022-06-06 08:00 3782

Gold Globee® Recognition Annature and founder CEO Amreeta Abbott at the Golden Bridge Awards

BRISBANE, Australia, June 6, 2022 /PRNewswire/ -- Annature CEO Amreeta Abbott has continued her run of international award recognition by being named Woman of the Year in Business and the Professions in the world's premier business awards program, the Globee® Awards.

2022-06-06 07:00 3402

Pepper Money's SOLANA Improves Business Volumes by 70% with the Appian Low-Code Platform

SYDNEY, June 6, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) announced today that Pepper Money, a leading consumer finance company inAustralia is using the  Appian Low-Code Platform to support its Asset Finance Loan Origination solution, SOLANA, which has allowed the company to grow its business vol...

2022-06-06 07:00 4393

LILYSILK Honors World Environment Day with Sustainable Living Initiatives

LOS ANGELES, June 5, 2022  /PRNewswire/ -- In conjunction with this year's World Environment Day , the world's leading silk brand LILYSILK is celebrating with zero-waste initiatives to champion a sustainable lifestyle, and contribute to a greener, better w...

2022-06-05 22:00 8202

IFF Kicks off Annual Green Finance Award Selection on World Environment Day

BEIJING, June 5, 2022 /PRNewswire/ -- The International Finance Forum (IFF) will start accepting applications for the annual IFF Global Green Finance Award, fromJune 5, which is also the World Environment Day. Echoing the theme of World Environment Day ,"Only One Earth", which stresses on  the n...

2022-06-05 21:45 4577

Angel Yeast Increases New Energy Procurement in Green Push to Curb Carbon Emission

YICHANG, China, June 5, 2022 /PRNewswire/ -- Angel Yeast (en.angelyeast.com) (SH600298), a listed global yeast and yeast extract manufacturer, is glad to announce that the Company has been granted the green electricity certificate issued and certified by China Hubei Power Exchange Center and Chin...

2022-06-05 21:00 5493

JW Therapeutics Presents Latest Data of Carteyva® at 2022 ASCO Annual Meeting

SHANGHAI, June 5, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, presented the latest data of three clinical studies on Carteyva® (relmacabtagene autoleuce...

2022-06-05 18:30 5533

CStone presents updated results of anti-PD-1 antibody nofazinlimab in combination with lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC) at ASCO 2022

* Nofazinlimab in combination with lenvatinib as first-line treatment for unresectable hepatocellular carcinoma demonstrated an objective response rate of 45.0%. The median duration of response was not yet reached as of the data cutoff date (4.2 to 18.7+ months). The median progression free sur...

2022-06-05 08:02 6085

Everest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients

FOSTER CITY, Calif. and SHANGHAI, June 4, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announces today that its licensing partner, Gilead Sciences, Inc. (Nasdaq: GILD), reported positive results from the primary analysis of the Phase 3 TROPiCS-02 study of Trodelvy® (sacituzumab govitecan...

2022-06-04 20:30 7402

Good Game Asia, World's First Live Gaming Reality TV Show, Premieres 10 June on Warner TV

Yup.gg founder and show creator anticipates it will bring gaming and esports into the mainstream SINGAPORE, June 4, 2022 /PRNewswire/ -- The highly anticipated new multi-channel reality showGood Game Asia  launches to a worldwide audience on 10 June. Hosted by t...

2022-06-04 15:50 8402

CStone presents clinical results of sugemalimab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma via an oral abstract session at ASCO 2022

* GEMSTONE-201 is the largest registrational clinical study of an anti-PD-(L)1 antibody reported so far in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL). * Results on the primary endpoint showed that sugemalimab significantly improved objective res...

2022-06-04 08:02 8234

Recon Receives NASDAQ Notification Regarding Minimum Bid Requirements

BEIJING, June 3, 2022 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company") today announced that onJune 1, 2022, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is currently not in compliance with the minimum bid price requ...

2022-06-04 04:30 7014

Dogness (International) Corporation Closes $12 Million Offering

DONGGUAN, China, June 3, 2022 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced that it closed a previously announced offerin...

2022-06-04 01:48 8781

Digital payments in India projected to reach $10 trillion by 2026: PhonePe Pulse and BCG release report on digital payments

Highlights of the report: * Value of digital payments in India to increase three-fold from US$3 trillion today toUS$10 trillion by 2026 * Digital payments will constitute nearly 65% of all payments by 2026, up from 40% today * UPI adoption will surge from 35% in FY 21 to 75% in the next fi...

2022-06-04 01:38 8077

bk World - The service station of the future has opened in Endsee, Germany

ENDSEE, Germany, June 4, 2022 /PRNewswire/ -- A new era has begun for drivers of electric cars. The first bk World opened today, Friday, in Endsee, Bavaria. By creating charging havens, this subsidiary of bk Group AG is revolutionising long-distance travel by electric car. From idea to reality ...

2022-06-04 01:08 7042

Dada Group's JDDJ fulfilled the first order in JD618 Grand Promotion, and saw sales surge

SHANGHAI, June 3, 2022 /PRNewswire/ -- On May 31, only 10 minutes after the official opening of JD618 Grand Promotion, one consumer who lives in Chaoyang District,Beijing, had received the milk powder and kid toys she bought from JDDJ. These products labeled with "Shop Now", are supported by Dada...

2022-06-03 23:45 7841

Gracell Biotechnologies Schedules Clinical Update Call After EHA2022

SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, June. 3, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today a...

2022-06-03 23:00 7028